Literature DB >> 14576121

In vitro and ex vivo activities of minocycline and EDTA against microorganisms embedded in biofilm on catheter surfaces.

Issam Raad1, Ioannis Chatzinikolaou, Gassan Chaiban, Hend Hanna, Ray Hachem, Tanya Dvorak, Guy Cook, William Costerton.   

Abstract

Minocycline-EDTA (M-EDTA) flush solution has been shown to prevent catheter-related infection and colonization in a rabbit model and in hemodialysis patients. We undertook this study in order to determine the activities of M-EDTA against organisms embedded in fresh biofilm (in vitro) and mature biofilm (ex vivo). For the experiment with the in vitro model, a modified Robbin's device (MRD) was used whereby 25 catheter segments were flushed for 18 h with 10(6) CFU of biofilm-producing Staphylococcus epidermidis, Staphylococcus aureus, and Candida albicans per ml. Subsequently, each of the catheter segments was incubated in one of the following solutions: (i) streptokinase, (ii) heparin, (iii) broth alone, (iv) vancomycin, (v) vancomycin-heparin, (vi) EDTA, (vii) minocycline (high-dose alternating with low-dose), or (viii) M-EDTA (low-dose minocycline alternating with high-dose minocycline were used to study the additive and synergistic activities of M-EDTA). All segments were cultured quantitatively by scrape sonication. For the experiment with the ex vivo model, 54 catheter tip segments removed from patients and colonized with bacterial organisms by roll plate were longitudinally cut into two equal segments and exposed to either saline, heparin, EDTA, or M-EDTA (with high-dose minocycline). Subsequently, all segments were examined by confocal laser electron microscopy. In the in vitro MRD model, M-EDTA (with a low concentration of minocycline) was significantly more effective than any other agent in reducing colonization of S. epidermidis, S. aureus, and C. albicans (P < 0.01). M-EDTA (with a high concentration of minocycline) eradicated all staphylococcal and C. albicans organisms embedded in the biofilm. In the ex vivo model, M-EDTA (with a high concentration of minocycline) reduced bacterial colonization more frequently than EDTA or heparin (P < 0.01). We concluded that M-EDTA is highly active in eradicating microorganisms embedded in fresh and mature biofilm adhering to catheter surfaces.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14576121      PMCID: PMC253809          DOI: 10.1128/AAC.47.11.3580-3585.2003

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  26 in total

1.  Direct confocal microscopy studies of the bacterial colonization in vitro of a silver-coated heart valve sewing cuff.

Authors:  G Cook; J W Costerton; R O Darouiche
Journal:  Int J Antimicrob Agents       Date:  2000-01       Impact factor: 5.283

Review 2.  EDTA, the traditional anticoagulant of haematology: with increased automation is it time for a review?

Authors:  D M Reardon; B Warner; E A Trowbridge
Journal:  Med Lab Sci       Date:  1991-01

3.  Comparison of methods for detection and enumeration of airborne microorganisms collected by liquid impingement.

Authors:  S Terzieva; J Donnelly; V Ulevicius; S A Grinshpun; K Willeke; G N Stelma; K P Brenner
Journal:  Appl Environ Microbiol       Date:  1996-07       Impact factor: 4.792

4.  Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement.

Authors:  I Raad; W Costerton; U Sabharwal; M Sacilowski; E Anaissie; G P Bodey
Journal:  J Infect Dis       Date:  1993-08       Impact factor: 5.226

5.  Efficacy of minocycline and EDTA lock solution in preventing catheter-related bacteremia, septic phlebitis, and endocarditis in rabbits.

Authors:  Issam Raad; Ray Hachem; Robert K Tcholakian; Robert Sherertz
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  Prevention of central venous catheter-related infections and thrombotic events in immunocompromised children by the use of vancomycin/ciprofloxacin/heparin flush solution: A randomized, multicenter, double-blind trial.

Authors:  K J Henrickson; R A Axtell; S M Hoover; S M Kuhn; J Pritchett; S C Kehl; J P Klein
Journal:  J Clin Oncol       Date:  2000-03       Impact factor: 44.544

7.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

8.  Antibiotics and prevention of microbial colonization of catheters.

Authors:  I Raad; R Darouiche; R Hachem; M Sacilowski; G P Bodey
Journal:  Antimicrob Agents Chemother       Date:  1995-11       Impact factor: 5.191

9.  A randomized, controlled trial of the efficacy of a heparin and vancomycin solution in preventing central venous catheter infections in children.

Authors:  W R Rackoff; M Weiman; D Jakobowski; R Hirschl; V Stallings; J Bilodeau; P Danz; L Bell; B Lange
Journal:  J Pediatr       Date:  1995-07       Impact factor: 4.406

10.  Effect of subinhibitory concentrations of clindamycin and trospectomycin on the adherence of Staphylococcus epidermidis in an in vitro model of vascular catheter colonization.

Authors:  N Khardori; E Wong; H Nguyen; C Jeffery-Wiseman; E Wallin; R P Tewari; G P Bodey
Journal:  J Infect Dis       Date:  1991-07       Impact factor: 5.226

View more
  34 in total

Review 1.  Candida biofilms: an update.

Authors:  Gordon Ramage; Stephen P Saville; Derek P Thomas; José L López-Ribot
Journal:  Eukaryot Cell       Date:  2005-04

2.  Combination of tigecycline and N-acetylcysteine reduces biofilm-embedded bacteria on vascular catheters.

Authors:  Saima Aslam; Barbara W Trautner; Venkat Ramanathan; Rabih O Darouiche
Journal:  Antimicrob Agents Chemother       Date:  2007-01-12       Impact factor: 5.191

Review 3.  Advances in the treatment of problematic industrial biofilms.

Authors:  D Xu; R Jia; Y Li; T Gu
Journal:  World J Microbiol Biotechnol       Date:  2017-04-13       Impact factor: 3.312

4.  D-amino acids for the enhancement of a binary biocide cocktail consisting of THPS and EDDS against an SRB biofilm.

Authors:  D Xu; J Wen; W Fu; T Gu; I Raad
Journal:  World J Microbiol Biotechnol       Date:  2011-12-11       Impact factor: 3.312

Review 5.  Bacterial biofilms: development, dispersal, and therapeutic strategies in the dawn of the postantibiotic era.

Authors:  Maria Kostakioti; Maria Hadjifrangiskou; Scott J Hultgren
Journal:  Cold Spring Harb Perspect Med       Date:  2013-04-01       Impact factor: 6.915

6.  Heparin stimulates Staphylococcus aureus biofilm formation.

Authors:  Robert M Q Shanks; Niles P Donegan; Martha L Graber; Sarah E Buckingham; Michael E Zegans; Ambrose L Cheung; George A O'Toole
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Fungal Biofilms: In Vivo Models for Discovery of Anti-Biofilm Drugs.

Authors:  Jeniel E Nett; David R Andes
Journal:  Microbiol Spectr       Date:  2015-06

8.  Optimal antimicrobial catheter lock solution, using different combinations of minocycline, EDTA, and 25-percent ethanol, rapidly eradicates organisms embedded in biofilm.

Authors:  Issam Raad; Hend Hanna; Tanya Dvorak; Gassan Chaiban; Ray Hachem
Journal:  Antimicrob Agents Chemother       Date:  2006-10-30       Impact factor: 5.191

9.  Chelator-based catheter lock solutions in eradicating organisms in biofilm.

Authors:  I Raad; J Rosenblatt; R Reitzel; Y Jiang; T Dvorak; R Hachem
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

Review 10.  Antifungal lock therapy.

Authors:  Carla J Walraven; Samuel A Lee
Journal:  Antimicrob Agents Chemother       Date:  2012-10-15       Impact factor: 5.191

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.